Brasov

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials
• Familial hypercholesterolaemia2 trials
• Stroke2 trials
• Sjögren's disease1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Novartis Pharmaceuticals4 trials

Running trials

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome

  NCT04541589· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

  NCT04023552· Phase 3· Novartis Pharmaceuticals· Source